
AXGN vs EYES
$AXGN vs $EYES head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
AXGN vs EYES: trend, levels and the market
One year to 2026-11-19, against the S&P 500 (-1.7%). Split-adjusted daily closes.
- ·Both beat the market over the past year: AXGN +29.4% and EYES +5.9%, against the S&P 500 at -1.7%.
- ·AXGN has support 18.1% below at $46.03; EYES has no tested support within 35% under its price.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
AXGN vs EYES: the quick read
- ·AXGN is the larger company by market cap ($3.40B vs $2.44B).
- ·AXGN has been more active on our scanner (151 vs 0 alerts in 30 days).
- ·AXGN has the smaller float (58.4M vs 90.2M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS vs Electromedical & Electrotherapeutic Apparatus), so they answer to different catalysts and a move in one says little about the other.
- ·Only one of them shows up on our scanner: AXGN triggered 151 unusual-volume alerts in the last 30 days and the other triggered none.
- ·They are closely matched in size, within 39% of each other on market cap, which makes the rest of this table the interesting part.
Objective differences only. Not investment advice.
Watching AXGN or EYES? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing AXGN and EYES on TheDesperateTrader.
- Is AXGN or EYES the better stock?
- "Better" depends on your goal, and these two are not alike. AXGN is the larger company by market cap ($3.40B vs $2.44B). AXGN has been more active on our scanner (151 vs 0 alerts in 30 days). AXGN has the smaller float (58.4M vs 90.2M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between AXGN and EYES?
- The differences that matter: they are not in the same business - AXGN is electromedical & electrotherapeutic apparatus and EYES is electromedical & electrotherapeutic apparatus; they are similar in size ($3.40B vs $2.44B); they trade at very different share prices ($56.20 vs $26.66); AXGN sits at 90% of its 52-week range against 38% for EYES; our scanner flagged AXGN 151 times in the last 30 days against 0 for EYES. Everything above is measured from the latest completed session and SEC filings.
- Which of AXGN and EYES is more active right now?
- Right now AXGN is at about 1.1x its normal volume and EYES is at about 1.9x, so EYES is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is AXGN or EYES in the stronger trend?
- AXGN is above its 50-day average of $44.06 and above its 200-day average of $40.95; EYES is below its 50-day average of $29.07. AXGN leads 4 of the 5 measures on this page (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading AXGN or EYES? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore AXGN and EYES comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.